MET and Cirrhosis: Our recent preclinical studies of short-term c-Met (24 h before functional cell transplantation) inhibition using anti-c-Met (HGF only receptor) antibody in DEN-induced liver fibrosis/cirrhosis before cell treatment have revealed that the cells exhibit improved functions of protecting transplant cells from apoptosis and improve functions 4 weeks after treatment (unpublished data).